15.3 C
New York
Friday, September 29, 2023

The Question Is Whether To Buy Or Not To Buy Esperion Therapeutics Inc. (NASDAQ: ESPR)

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Esperion Therapeutics Inc. (ESPR) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.02, or 1.55%, to $1.31. The Esperion Therapeutics Inc. has recorded 11,075 volume in the after hours trading session. The stock was recently discussed on Yahoo Finance as it revealed that American College of Cardiology Program to Increase Cholesterol Screenings.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Stocks Info

Esperion Therapeutics Inc. is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Drug Manufacturers – Specialty & Generic industry. At the end of the last regular session, the stock closed at $1.29 and fluctuated between $1.3890 as its day high and $1.2800 as its day low. The current market capitalization of Esperion Therapeutics Inc. is $138.00M. A total of 4.17 million shares were traded on the day, compared to an average of 3.24M shares.

Insider Activity

Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, ESPR has seen 8 BUY and 2 SELL insider trades, representing the acquisition of 41,200 and the disposition of 709 shares. Over the last 12 months, there were 18 BUYs and 18 SELLs from insiders. Insiders purchased 330,561 shares during that period but sold 41,255.

In the most recent transaction, Warren Eric sold 243 shares of ESPR for 1.41 per share on Aug 18. After the transaction, the Chief Commercial Officer now owns 69,060 company shares. In a previous transaction on Jul 19, Warren Eric sold 106 shares at 1.58 per share. ESPR shares that Chief Commercial Officer owns now total 69,303.

Among the insiders who sold shares, Warren Eric disposed of 603 shares on Jun 21 at a per-share price of $1.48. This resulted in the Chief Commercial Officer holding 69,409 shares of ESPR after the transaction. In another insider transaction, Warren Eric sold 219 shares at $1.62 per share on May 17. Company shares held by the Chief Commercial Officer now total 70,012.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for ESPR in the last 3 months, the mean price target is $10.28 with high estimates of $22.00 and low estimates of $2.00. In terms of 52-week highs and lows, ESPR has a high of $8.87 and a low of $1.12.

As of this writing, ESPR has an earnings estimate of -$0.43 per share for the current quarter. EPS was calculated based on a consensus of 9 estimates, with a high estimate of -$0.37 per share and a lower estimate of -$0.49. The company reported an EPS of -$0.79 in the last quarter, which was -21.50% lower than expectations of -$0.65.

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. ESPR’s latest balance sheet shows that the firm has $208.89M in Cash & Short Term Investments as of fiscal 2021. There were $260.20M in debt and $73.35M in liabilities at the time. Its Book Value Per Share was -$3.41, while its Total Shareholder’s Equity was -$196.94M.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ESPR is Buy with a score of 4.57.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles